{
    "nctId": "NCT04832191",
    "briefTitle": "CE-MRI&CESM in Solid Breast Lesions",
    "officialTitle": "1.3 Role of Contrast-enhanced Mammography and Dynamic Contrast-enhanced MRI in the Assessment of Solid Breast Lesions",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Neoplasms",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 50,
    "primaryOutcomeMeasure": "comparison between accuracy of CESM and CE-MRI in diagnosing breast cancer.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients who have previously undergone mammography (MG) and ultrasound and have a solid (BIRADs III and more) breast lesion.\n\nExclusion Criteria:\n\n* Cystic breast lesions\n* BIRADs I and II breast lesions(benign)\n* Pregnancy\n* History of allergic reaction to iodinated contrast agent\n* Renal insufficiency\n* Other contraindications to MRI include pacemaker, claustrophobia or metal prosthesis.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}